A new study published in the journal Arthritis Care & Research, led by Dr. Mary-Ann Fitzcharles, a rheumatologist at the McGill University Health Centre, reveals that 13 per cent of FM patients use cannabinoids for relief from symptoms such as widespread pain, fatigue, and insomnia.
Patients taking medication to prevent heart attack as well as anti-depressants have a higher risk of developing internal bleeding, according to a new study conducted by researchers at the McGill University Health Centre (MUHC). The results were published this week in the Canadian Medical Association Journal.
As part of McGill's "RaDiCAL" project (Rare Disease Consortium for Autosomal Loci), collaborators in Qatar conducted field research with three patients from biologically interrelated Bedouin families, and sent samples to Canada for analysis by GA JOE – a high-tech genome analyzing machine.
Premier, ministers, mayor join in ceremony By McGill Reporter Staff A key step toward the construction of a new McGill University Health Centre at the Glen Yards was taken April 1, as Premier Jean Charest, flanked by cabinet ministers and MUHC and McGill leaders and Mayor Gérald Tremblay, announced to a crowded room the selection of McGill [...]
The Honourable Leona Aglukkaq, Minister of Health, on behalf of the Government of Canada, has announced it will be providing five million doses of H1N1 flu vaccine to Mexico to help bridge that country's immediate pandemic vaccine requirements.
The H1N1 flu virus may mean that caregivers have to work longer hours and they may have to help those they care for manage the physical and emotional issues associated with the H1N1 flu.
Some Reactions to Expect.How You Can Help. Focus On What They Can Do To Stay Healthy. If Your Teen Gets the H1N1 Flu. If Teens are Babysitting a Child with Flu Symptoms
Guidance for expanded use of oseltamivir (Tamiflu®) in children under one year of age in the context of Pandemic (H1N1) 2009
This guidance has been updated based on current scientific evidence, expert opinion and the Interim Order, issued by the Federal Minister of Health, permitting the expanded use of oseltamivir for the influenza A H1N1 virus in children under 1 year of age